Bayer Exploring Sale of Diabetes Unit for Up to $2.5B

The transcript discusses Bayer's potential sale of its diabetes device business, with private equity firms like Cinven and Triton Advisors showing interest. The unit could be valued between €1 billion and 2 billion. Bayer is also planning to list its plastics unit on the stock market and is in the process of acquiring MERCS' over-the-counter drug business for $14 billion. Additionally, Bayer might be interested in acquiring Zoetis, an animal health company previously part of Pfizer.

What is the potential sale being discussed in relation to the diabetes device business?

Evaluate responses using AI:

OFF

Which private equity firms are mentioned as potentially interested in the sale?

Evaluate responses using AI:

OFF

What is the estimated value range for the unit that could be sold?

Evaluate responses using AI:

OFF

What significant acquisition is Bear planning in the healthcare sector?

Evaluate responses using AI:

OFF

Which company is mentioned as a potential target for acquisition in the animal health sector?

Evaluate responses using AI:

OFF